维生素D、钙或联合补充用于社区成人骨折一级预防:美国预防服务工作组证据报告与系统综述
结果显示,单独维生素D或联合钙均与骨折发生率降低无关,而维生素D联合钙与肾结石发生率增加相关。
要点
- 在无已知维生素D缺乏、骨质疏松或既往骨折的社区成人中,补充维生素D(单用或联合钙)未降低骨折风险。
- 维生素D联合钙补充与肾结石发生率增加相关(合并绝对风险差0.33%,95%CI 0.06%至0.60%)。
- 补充维生素D或联合钙对全因死亡率、心血管疾病发生率无显著影响。
核心结论
- 在无已知维生素D缺乏、骨质疏松或既往骨折的社区居住成人中,单独补充维生素D或联合钙均与骨折发生率降低无关。
- 维生素D联合钙补充与肾结石发生率增加相关。
研究设计与样本
- 检索PubMed、EMBASE、Cochrane图书馆及试验注册库至2017年3月21日,监测至2018年2月28日。
主要发现
- 与安慰剂相比,维生素D补充降低总骨折发生率(1项RCT,n=2686;绝对风险差-2.26%,95%CI -4.53%至0.00%),但与髋部骨折无显著关联(3项RCT,n=5496;合并绝对风险差-0.01%,95%CI -0.80%至0.78%)。
- 维生素D联合钙对总骨折发生率无影响(1项RCT,n=36 282;绝对风险差-0.35%,95%CI -1.02%至0.31%),对髋部骨折发生率亦无影响(2项RCT,n=36 727;较大试验绝对风险差-0.14%,95%CI -0.34%至0.07%)。
- 单独钙补充证据有限,仅2项研究(n=339),结果极不精确。
- 维生素D单用或联合钙对全因死亡率或心血管疾病发生率无显著影响,绝对风险差范围-1.93%至1.79%。
- 维生素D联合钙与肾结石发生率增加相关(3项RCT,n=39 213;合并绝对风险差0.33%,95%CI 0.06%至0.60%),单独钙补充未增加风险(3项RCT,n=1259;合并绝对风险差0.00%,95%CI -0.87%至0.87%)。
临床怎么用
- 对于无已知维生素D缺乏、骨质疏松或既往骨折的社区居住成人,不应仅以骨折一级预防为目的常规推荐维生素D单用或联合钙补充。
- 处方维生素D联合钙时需权衡肾结石风险增加。
局限性
- 单独钙补充的证据有限,仅2项研究且结果极不精确。
- 研究排除 institutionalized 人群及已知维生素D缺乏、骨质疏松或既往骨折者,结论不适用于这些人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Osteoporotic fractures result in significant morbidity and mortality. OBJECTIVE: To update the evidence for benefits and harms of vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults to inform the US Preventive Services Task Force. DATA SOURCES: PubMed, EMBASE, Cochrane Library, and trial registries through March 21, 2017; references; and experts. Surveillance continued through February 28, 2018. STUDY SELECTION: English-language randomized clinical trials (RCTs) or observational studies of supplementation with vitamin D, calcium, or both among adult populations; studies of populations that were institutionalized or had known vitamin D deficiency, osteoporosis, or prior fracture were excluded. DATA EXTRACTION AND SYNTHESIS: Dual, independent review of titles/abstracts and full-text articles and study quality rating using predefined criteria. Random-effects meta-analysis used when at least 3 similar studies were available. MAIN OUTCOMES AND MEASURES: Incident fracture, mortality, kidney stones, cardiovascular events, and cancer. RESULTS: Eleven RCTs (N = 51 419) in adults 50 years and older conducted over 2 to 7 years were included. Compared with placebo, supplementation with vitamin D decreased total fracture incidence (1 RCT [n = 2686]; absolute risk difference [ARD], -2.26% [95% CI, -4.53% to 0.00%]) but had no significant association with hip fracture (3 RCTs [n = 5496]; pooled ARD, -0.01% [95% CI, -0.80% to 0.78%]). Supplementation using vitamin D with calcium had no effect on total fracture incidence (1 RCT [n = 36 282]; ARD, -0.35% [95% CI, -1.02% to 0.31%]) or hip fracture incidence (2 RCTs [n = 36 727]; ARD from the larger trial, -0.14% [95% CI, -0.34% to 0.07%]). The evidence for calcium alone was limited, with only 2 studies (n = 339 total) and very imprecise results. Supplementation with vitamin D alone or with calcium had no significant effect on all-cause mortality or incident cardiovascular disease; ARDs ranged from -1.93% to 1.79%, with CIs consistent with no significant differences. Supplementation using vitamin D with calcium was associated with an increased incidence of kidney stones (3 RCTs [n = 39 213]; pooled ARD, 0.33% [95% CI, 0.06% to 0.60%]), but supplementation with calcium alone was not associated with an increased risk (3 RCTs [n = 1259]; pooled ARD, 0.00% [95% CI, -0.87% to 0.87%]). Supplementation with vitamin D and calcium was not associated with an increase in cancer incidence (3 RCTs [n = 39 213]; pooled ARD, -1.48% [95% CI, -3.32% to 0.35%]). CONCLUSIONS AND RELEVANCE: Vitamin D supplementation alone or with calcium was not associated with reduced fracture incidence among community-dwelling adults without known vitamin D deficiency, osteoporosis, or prior fracture. Vitamin D with calcium was associated with an increase in the incidence of kidney stones.
引用
- Kahwati LC, Weber RP, Pan H, et al. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018. PMID: 29677308. doi:10.1001/jama.2017.21640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。